CCP
ABBV icon

Corient Capital Partners’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$14.7M Hold
96,108
1.1% 12
2022
Q2
$14.7M Buy
96,108
+191
+0.2% +$29.3K 1.12% 12
2022
Q1
$15.5M Buy
95,917
+6,576
+7% +$1.07M 1.03% 13
2021
Q4
$12.1M Buy
89,341
+2,985
+3% +$404K 0.8% 19
2021
Q3
$9.32M Sell
86,356
-3,200
-4% -$345K 0.68% 28
2021
Q2
$10.1M Buy
89,556
+13,799
+18% +$1.55M 0.74% 22
2021
Q1
$8.2M Buy
75,757
+1,961
+3% +$212K 0.7% 23
2020
Q4
$7.91M Buy
73,796
+4,092
+6% +$438K 0.79% 25
2020
Q3
$6.11M Buy
69,704
+1,130
+2% +$99K 0.7% 34
2020
Q2
$6.73M Buy
68,574
+13,243
+24% +$1.3M 0.82% 24
2020
Q1
$4.22M Buy
55,331
+13,187
+31% +$1M 0.66% 37
2019
Q4
$3.73M Buy
42,144
+1,626
+4% +$144K 0.47% 50
2019
Q3
$3.07M Buy
40,518
+833
+2% +$63.1K 0.43% 55
2019
Q2
$2.89M Sell
39,685
-1,520
-4% -$111K 0.44% 50
2019
Q1
$3.32M Sell
41,205
-10,616
-20% -$856K 0.54% 41
2018
Q4
$4.78M Sell
51,821
-12,875
-20% -$1.19M 0.85% 18
2018
Q3
$6.12M Hold
64,696
1.02% 9
2018
Q2
$5.99M Buy
64,696
+2,574
+4% +$238K 1.05% 8
2018
Q1
$5.88M Sell
62,122
-16,551
-21% -$1.57M 1.08% 11
2017
Q4
$7.61M Sell
78,673
-17,008
-18% -$1.64M 1.29% 6
2017
Q3
$8.5M Sell
95,681
-8,436
-8% -$750K 1.61% 6
2017
Q2
$7.55M Sell
104,117
-1,514
-1% -$110K 1.16% 11
2017
Q1
$6.88M Buy
105,631
+21,349
+25% +$1.39M 1.07% 15
2016
Q4
$5.28M Sell
84,282
-7,674
-8% -$481K 0.93% 16
2016
Q3
$5.8M Buy
+91,956
New +$5.8M 1.07% 11